Cargando…

Quantification of cortisol and its metabolites in human urine by LC-MS(n): applications in clinical diagnosis and anti-doping control

The objective of the current research was to develop a liquid chromatography-MS(n) (LC-MS(n)) methodology for the determination of free cortisol and its 15 endogenous metabolites (6β-hydroxycortisol, 20α-dihydrocortisol, 20α-dihydrocortisone, 20-β-dihydrocortisol, 20β-dihydrocortisone, prednisolone,...

Descripción completa

Detalles Bibliográficos
Autores principales: Arioli, Francesco, Gamberini, Maria Cristina, Pavlovic, Radmila, Di Cesare, Federica, Draghi, Susanna, Bussei, Giulia, Mungiguerra, Francesca, Casati, Alessio, Fidani, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436849/
https://www.ncbi.nlm.nih.gov/pubmed/35915250
http://dx.doi.org/10.1007/s00216-022-04249-3
_version_ 1784781465220808704
author Arioli, Francesco
Gamberini, Maria Cristina
Pavlovic, Radmila
Di Cesare, Federica
Draghi, Susanna
Bussei, Giulia
Mungiguerra, Francesca
Casati, Alessio
Fidani, Marco
author_facet Arioli, Francesco
Gamberini, Maria Cristina
Pavlovic, Radmila
Di Cesare, Federica
Draghi, Susanna
Bussei, Giulia
Mungiguerra, Francesca
Casati, Alessio
Fidani, Marco
author_sort Arioli, Francesco
collection PubMed
description The objective of the current research was to develop a liquid chromatography-MS(n) (LC-MS(n)) methodology for the determination of free cortisol and its 15 endogenous metabolites (6β-hydroxycortisol, 20α-dihydrocortisol, 20α-dihydrocortisone, 20-β-dihydrocortisol, 20β-dihydrocortisone, prednisolone, cortisone, α-cortolone, β-cortolone, allotetrahydrocortisol, 5α-dihydrocortisol, tetrahydrocortisol, allotetrahydrocortisone, 5β-dihydrocortisol, tetrahydrocortisone) in human urine. Due to its optimal performance, a linear ion trap operating in ESI negative ion mode was chosen for the spectrometric analysis, performing MS(3) and MS(4) experiments. The method was validated for limit of detection (LOD) and limit of quantification (LOQ) (0.01 ng mL(−1) and 0.05 ng mL(−1), for all compounds, respectively), intra- and inter-day precision (CV = 1.4–9.2% and CV = 3.6–10.4%, respectively), intra- and inter-day accuracy (95–110%), extraction recovery (65–95%), linearity (R2 > 0.995), and matrix effect that was absent for all molecules. Additionally, for each compound, the percentage of glucuronated conjugates was estimated. The method was successfully applied to the urine (2 mL) of 50 healthy subjects (25 males, 25 females). It was also successfully employed on urine samples of two patients with Cushing syndrome and one with Addison’s disease. This analytical approach could be more appropriate than commonly used determination of urinary free cortisol collected in 24-h urine. The possibility of considering the differences and relationship between cortisol and its metabolites allows analytical problems related to quantitative analysis of cortisol alone to be overcome. Furthermore, the developed method has been demonstrated as efficient for antidoping control regarding the potential abuse of corticosteroids, which could interfere with the cortisol metabolism, due to negative feedback on the hypothalamus-hypophysis-adrenal axis. Lastly, this method was found to be suitable for the follow-up of prednisolone that was particularly important considering its pseudo-endogenous origin and correlation with cortisol metabolism. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-9436849
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-94368492022-09-03 Quantification of cortisol and its metabolites in human urine by LC-MS(n): applications in clinical diagnosis and anti-doping control Arioli, Francesco Gamberini, Maria Cristina Pavlovic, Radmila Di Cesare, Federica Draghi, Susanna Bussei, Giulia Mungiguerra, Francesca Casati, Alessio Fidani, Marco Anal Bioanal Chem Research Paper The objective of the current research was to develop a liquid chromatography-MS(n) (LC-MS(n)) methodology for the determination of free cortisol and its 15 endogenous metabolites (6β-hydroxycortisol, 20α-dihydrocortisol, 20α-dihydrocortisone, 20-β-dihydrocortisol, 20β-dihydrocortisone, prednisolone, cortisone, α-cortolone, β-cortolone, allotetrahydrocortisol, 5α-dihydrocortisol, tetrahydrocortisol, allotetrahydrocortisone, 5β-dihydrocortisol, tetrahydrocortisone) in human urine. Due to its optimal performance, a linear ion trap operating in ESI negative ion mode was chosen for the spectrometric analysis, performing MS(3) and MS(4) experiments. The method was validated for limit of detection (LOD) and limit of quantification (LOQ) (0.01 ng mL(−1) and 0.05 ng mL(−1), for all compounds, respectively), intra- and inter-day precision (CV = 1.4–9.2% and CV = 3.6–10.4%, respectively), intra- and inter-day accuracy (95–110%), extraction recovery (65–95%), linearity (R2 > 0.995), and matrix effect that was absent for all molecules. Additionally, for each compound, the percentage of glucuronated conjugates was estimated. The method was successfully applied to the urine (2 mL) of 50 healthy subjects (25 males, 25 females). It was also successfully employed on urine samples of two patients with Cushing syndrome and one with Addison’s disease. This analytical approach could be more appropriate than commonly used determination of urinary free cortisol collected in 24-h urine. The possibility of considering the differences and relationship between cortisol and its metabolites allows analytical problems related to quantitative analysis of cortisol alone to be overcome. Furthermore, the developed method has been demonstrated as efficient for antidoping control regarding the potential abuse of corticosteroids, which could interfere with the cortisol metabolism, due to negative feedback on the hypothalamus-hypophysis-adrenal axis. Lastly, this method was found to be suitable for the follow-up of prednisolone that was particularly important considering its pseudo-endogenous origin and correlation with cortisol metabolism. GRAPHICAL ABSTRACT: [Image: see text] Springer Berlin Heidelberg 2022-08-02 2022 /pmc/articles/PMC9436849/ /pubmed/35915250 http://dx.doi.org/10.1007/s00216-022-04249-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Paper
Arioli, Francesco
Gamberini, Maria Cristina
Pavlovic, Radmila
Di Cesare, Federica
Draghi, Susanna
Bussei, Giulia
Mungiguerra, Francesca
Casati, Alessio
Fidani, Marco
Quantification of cortisol and its metabolites in human urine by LC-MS(n): applications in clinical diagnosis and anti-doping control
title Quantification of cortisol and its metabolites in human urine by LC-MS(n): applications in clinical diagnosis and anti-doping control
title_full Quantification of cortisol and its metabolites in human urine by LC-MS(n): applications in clinical diagnosis and anti-doping control
title_fullStr Quantification of cortisol and its metabolites in human urine by LC-MS(n): applications in clinical diagnosis and anti-doping control
title_full_unstemmed Quantification of cortisol and its metabolites in human urine by LC-MS(n): applications in clinical diagnosis and anti-doping control
title_short Quantification of cortisol and its metabolites in human urine by LC-MS(n): applications in clinical diagnosis and anti-doping control
title_sort quantification of cortisol and its metabolites in human urine by lc-ms(n): applications in clinical diagnosis and anti-doping control
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436849/
https://www.ncbi.nlm.nih.gov/pubmed/35915250
http://dx.doi.org/10.1007/s00216-022-04249-3
work_keys_str_mv AT ariolifrancesco quantificationofcortisolanditsmetabolitesinhumanurinebylcmsnapplicationsinclinicaldiagnosisandantidopingcontrol
AT gamberinimariacristina quantificationofcortisolanditsmetabolitesinhumanurinebylcmsnapplicationsinclinicaldiagnosisandantidopingcontrol
AT pavlovicradmila quantificationofcortisolanditsmetabolitesinhumanurinebylcmsnapplicationsinclinicaldiagnosisandantidopingcontrol
AT dicesarefederica quantificationofcortisolanditsmetabolitesinhumanurinebylcmsnapplicationsinclinicaldiagnosisandantidopingcontrol
AT draghisusanna quantificationofcortisolanditsmetabolitesinhumanurinebylcmsnapplicationsinclinicaldiagnosisandantidopingcontrol
AT busseigiulia quantificationofcortisolanditsmetabolitesinhumanurinebylcmsnapplicationsinclinicaldiagnosisandantidopingcontrol
AT mungiguerrafrancesca quantificationofcortisolanditsmetabolitesinhumanurinebylcmsnapplicationsinclinicaldiagnosisandantidopingcontrol
AT casatialessio quantificationofcortisolanditsmetabolitesinhumanurinebylcmsnapplicationsinclinicaldiagnosisandantidopingcontrol
AT fidanimarco quantificationofcortisolanditsmetabolitesinhumanurinebylcmsnapplicationsinclinicaldiagnosisandantidopingcontrol